---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-058240"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:37:18.107273+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Guardant Health director Meresman to leave board; governance reforms adopted

## Summary
- Stanley Meresman, a Class I director, will not stand for re-election at June 2022 annual meeting; no disagreement.
- Board expanded from 7 to 9 directors, now includes 4 women.
- Nominating Committee charter amended to oversee ESG, ethical compliance, IT healthcare regulatory compliance.
- Code of Conduct updated with broader standards on conflicts, antitrust, political contributions, social media.
- Committee assignments effective May 1, 2022: Audit (Meresman), Compensation (Gadde), Nominating (Clark).

## SEC filing metadata
- accession: 0001193125-22-058240
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312522058240/0001193125-22-058240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312522058240/d203874d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-058240
- JSON: https://secwatch.observer/filing/0001193125-22-058240.json
- Plain text: https://secwatch.observer/filing/0001193125-22-058240.txt

## Key facts
- Executive change
  Stanley Meresman departed as Director at Guardant Health, Inc..
  - Action: will not stand for re-election
  - Role: Director
  source text: On February 22, 2022, Stanley Meresman informed Guardant Health, Inc. (the “Company”) that he will not stand for re-election to the Company’s Board of Directors (the “Board”) when his current term expires at the Company’s next Annual Meeting of Stockholders, which will take place in June 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312522058240/0001193125-22-058240-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.